Navigation Links
FDA, Medical Device Industry and NORD Announce New Public-Private Partnership
Date:12/3/2012

WASHINGTON, Dec. 3, 2012 /PRNewswire-USNewswire/ -- Senators Amy Klobuchar and Al Franken joined Food and Drug Commissioner Margaret Hamburg, MD, NORD President Peter L. Saltonstall and others today in a Capitol Hill event to announce the launch of a new public-private partnership aimed at promoting the development of innovative medical devices for patients.

(Logo: http://photos.prnewswire.com/prnh/20110719/DC37656LOGO-b)

The founding members of the new partnership, which will be called the Medical Device Innovation Consortium (MDIC), are LifeScience Alley, a biomedical science trade association; several companies involved in developing medical devices; and NORD (the National Organization for Rare Disorders), in partnership with the U.S. Food and Drug Administration (FDA).

"We at NORD are especially honored to be the first and only patient organization to be invited to be a founding member of the consortium," Saltonstall said in his remarks at the launch today.  "Over the past several years, we have sought to forge a productive relationship with the FDA and the medical devices industry because we believe that progress can be made only if all segments of the medical system work together.  We hope this public-private partnership will serve as a model for additional collaboration."

The mission of MDIC will be to foster innovation, increase the tools available to evaluate new medical devices to assure that they are safe and effective, and ensure that innovative devices get to patients as quickly as possible while still protecting public health.

Speakers at this morning's Capitol Hill announcement, in addition to Saltonstall, included among others:

  • Senator Amy Klobuchar (MN)
  • Senator Al Franken (MN)
  • FDA Commissioner Margaret Hamburg, MD
  • FDA Center for Devices and Radiological Health (CDRH) Director Jeffrey Shuren, MD, JD
  • Centers for Medicare and Medicaid Services, Deputy Director, Coverage and Analysis Group Tamara Syrek Jensen, JD
  • Immucor Inc. CEO William Hawkins
  • LifeScience Alley President and CEO Dale Wahlstrom

In his remarks, Saltonstall said that NORD's role would be to provide the patient perspective in the new partnership.  Noting that only about 250 of the nearly 7,000 rare diseases have treatments, he said that NORD's "highest priority is to help create and encourage an environment in which new treatments can be developed and made available to patients.

"We hope and expect that this new consortium will make an important contribution in addressing some of the strategic needs of the medical devices industry," Saltonstall added.  "A robust industry and an efficient and transparent FDA are absolutely essential to the development of innovative new treatments."

MDIC will draw together experts from FDA, the medical device industry, academia and related organizations to improve health through the application of shared knowledge.  Specific goals include:

  • To ensure that innovative technology is readily available to U.S. patients
  • To make the medical device regulatory process more expeditious, transparent and effective
  • To reduce the risk and expense of clinical research and
  • To reduce the time and cost of medical device development.

SOURCE National Organization for Rare Disorders (NORD)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Saint-Gobain Performance Plastics acquires Twin Bay Medical
2. Global Market for Medical Device Electrodes to Reach $1.43 billion, Technological Innovations and Developing Markets Fuel Demand for Neurological Monitoring and Digital Radiography
3. MedicalMine Inc.s ChARM EHR Receives ONC-ATCB Certification By Drummond Group
4. Cadence to Open Finished Medical Device Facility
5. Cynosure to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
6. Polymers in Medical Devices: Opportunities Arising and Trends Impacting the Market
7. The NeuViz 64 Multi-slice CT Scanner from Neusoft Medical Systems Receives FDA Clearance
8. Global Healthcare Analytics/Medical Analytics Market worth $10.8 Billion by 2017
9. Samsung Medison Showcases New Medical Equipment and Technology with Samsung Electronics at RSNA 2012
10. Rochester Medical Corporation to Participate in The Benchmark Company, LLC Micro Cap Discovery Conference
11. University Hospitals and Philips Healthcare to Showcase State-of-the-art Imaging Technology at Cleveland Medical Mart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):